Win a prize by stopping at every ride (booth) at the Microbe Theme Park (exhibit hall)! Snap a pic with your best buggies in the exhibit hall at the MAD-ID & SIDP Annual Meeting!

Must see content at #ESCMIDGlobal2026 presented by Dr. Olivia Funk & team as she shares a persistent MRSA bacteremia case in which clearance was only achieved after initiation of daptomycin-ceftaroline-gentamicin. An in vitro time kills analysis & genomic sequencing were completed.

Join Dr. Astha Bijwe as she shares her experience with a case of Bacillus thuringiensis endophthalmitis, with only a handful of reported cases of clinical infection. Happening today at #ESCMIDGlobal2026!

You won’t want to miss this one! Closing out #ESCMIDGlobal2026 with a bang from Dr. Stormmy Boettcher and team as she shares their findings on use of automated AST reporting & clinical implications.

Card limitation uncertainty & delayed AST results contributed to antibiotic modifications.

No better way to wrap up #ESCMIDGlobal2026 than by hearing from our expert SIDP & ACCP ID PRN member presenters like the great Dr. Brad Langford as he shares his wisdom on use of AI in Stewardship! Today at 830am!

Learn about practical strategies to leverage novel tools in your daily practice!

Join Dr. Melanie Nicol at #ESCMIDGlobal2026 as she discusses key drug-drug interactions with dolutegravir! Among those below 4xPAIC90, most achieved viral suppression or low viral loads. Twice daily dolutegravir may be an option for individuals with HIV receiveing 1HP for latent TB infection.

Be sure to catch this one from Dr. Sean Van Helden as he shares his team's real world experience with eravacycline. In patients with bloodstream infections treated with eravacycline, 74% had clinical success and a 30-day infection-related mortality rate of 11%. #ESCMIDGlobal2026

Great way to spend your Monday in Munich with Dr. Vikas Gupta as he shares his work to evaluate rapid susceptibility testing at #ESCMIDGlobal2026!

This feasibility study of this rapid AST system direct from isolated colonies indicates good overall antibiotic performance vs highly-resistant GNRs. 🧫

Ever fooled by negative rapid blood PCR testing? Dr. Stormmy Boettcher is at #ESCMIDGlobal2026 with some helpful insight! Their group's work found approximately 15% of positive blood cultures were “not detected” on BCID2, most commonly CoNS & viridans streptococci. Early pattern recognition is key!

She's a brilliant & busy woman this #ESCMIDGlobal2026! Hear from Dr. Stormmy Boettcher as she shares how Epic Cosmos demonstrated recurrent CDI rates of 36% (live-jslm) & 28% (live-brpk), with frequent post-FMT antibiotic exposure (~20-24%). Higher-than-trial recurrence highlights patient complexity

Be sure not to miss this gem at today's #ESCMIDGlobal2026 Poster Session! Dr. Sean Van Helden and team share their findings. Phage combined with delafloxacin demonstrated robust antibiofilm activity against Pseudomonas aeruginosa biofilms and consistently exceeded the activity of phage–ciprofloxacin

Want more BLI action? Dr. Keith Rodvold is here to help! Hear how repeated IMI 500 mg-cilastatin 500 mg-funobactam 250 mg in healthy subjects resulted in AUC ratios of ELF & alveolar macrophages to unbound plasma for IMI of 0.318 & 0.168 & funobactam of 0.352 & 0.366, respectively. #ESCMIDGlobal2026

She's schooling us from all angles today at #ESCMIDGlobal2026! Join the high-performing team led by Dr. Stormmy Boettcher as they discuss optimal antibiotic durations among solid organ transplant recipients with CAP! 🫁 💊

Early data support shorter is better in transplant patients!

Data is key! Hear from Dr. Debra Goff today at #ESCMIDGlobal2026 as she discusses her team's work on the impact of data feedback on antibiotic use!

Private Practice dentists rapidly changed their antibiotic prescribing after ASP education & implementation of self-monitored antibiotic dashboards.

Want to know how well we are managing Trich? Find out from Dr. Stormmy Boettcher & team today at #ESCMIDGlobal2026!

Despite 2021 CDC guidance, single-dose metronidazole persisted in ~18% of cases, declining to ~10% by 2025 per Epic Cosmos. Key Gap: 1 in 10 women still receive non-guideline therapy!

Looking for great science in Munich? We've got you covered! Join SIDP member Dr. Michael Vala as he highlights his team's findings which show how the addition of ertapenem was associated with prompt culture clearance and similar ADR risk profile compared to monotherapy. #ESCMIDGlobal2026

Cool science happening at #ESCMIDGlobal2026! Don't miss Dr. Keith Rodvold as he discusses findings on a novel beta-lactamase inhibitor therapy!

Repeated 3hr IV infusion of meropenem 2 g + pilabactam 1 g was safe & generally well tolerated in healthy participants. Join for more PK/PD details!

Double duty at #ESCMIDGlobal2026 this Sunday! Be sure not to miss Dr. Sean Van Helden as he shares their work highlighting omadacycline in real-world practice!

Omadacycline as oral transition therapy following bloodstream infection led to clinical success in 85.7% of patients & 7.1% 90-day morality

Be on the lookout for this one at #ESCMIDGlobal2026! Check out SIDP member Astha Bijwe as she shares her work on NTM PJI!

This study describes the clinical course, management, & outcomes of NTM-related PJI cases treated at a tertiary care hospital in Mumbai to better define optimal mgmt strategies!

Heads up PK/PD fans at #ESCMIDGlobal2026, don't miss this one! Dr. Cecilia Volk shares her team's work to better understand oritavancin exposures with multiple doses!

Weekly oritavancin dosing maintains serum conc well above relevant MICs despite PK/PD targets not being well-established.

Join Dr. Stormmy Boettcher and team at #ESCMIDGlobal2026 as she shares their work on the use of donor lung cultures to guide optimal management! 🫁

Observed frequent continued use of broad spectrum therapy & opportunities to promote targeted stewardship to reduce unnecessary exposure after 72hrs!

Check out SIDP member Lucy Ochola at #ESCMIDGlobal2026 as she shares her work demonstrating how targeted structural and educational interventions on diagnostic and antimicrobial stewardship improve focused treatment with increased microbiology utilization! 🧫

Check out Dr. Melanie Nicol at #ESCMIDGlobal2026 as she shares her findings! In participants with cryptococcal meningitis, oteseconazole achieved durable plasma concentrations exceeding the predefined 10 µg/mL plasma target & demonstrated low but measurable CSF penetration above Cryptococcus MIC90.

One not to miss! Join SIDP member, Julian Ermtraud as he highlights his impressive findings of a prospective multi-center clinical trial on the treatment of complicated urinary tract infections with temocillin!

Increased dosing leads to higher PK-PD target attainment & new PK-informed dosing scheme

Calling all of Munich & beyond! Be sure not to miss the amazing Dr. Stormmy Boettcher and team as she presents their findings at #ESCMIDGlobal2026.

Key Takeaway: Epic Cosmos data show S. maltophilia treatment remains dominated by TMP-SMX and levofloxacin & rare use of Ceftazidime/Avibactam + Aztreo

Headed to Munich for #ESCMIDGlobal2026? Don't miss the fabulous Dr. Taryn Eubank as she shares her work on the impact of Enterococcus on Cdiff severity!

Key Takeaway: Likely that other microorganisms contribute to Cdiff severity & the association with Enterococcus via this metabolomic analyses 💩

Be sure to check out Dr. Vikas Gupta as he shares his work at #ESCMIDGlobal2026!

He highlights findings which demonstrate that remnant suspension from ASTar enabled high performance pathogen ID & genotypic testing with future potential to reduce costs related to automated multiplex platforms 🔬

No better way to spend time at #ESCMIDGlobal2026 than hearing from the brilliant Dr. Tim Gauthier and team!

They found that diagnostic stewardship-focused education followed by removal of pneumococcal urinary antigen tests from order sets resulted in reduced inappropriate ordering. 🧫

We had an incredible time at #SHEASpring2026 last week! See what our SIDP & ACCP ID PRN members were up to in Chicago!

Terrific sessions to highlight the advancements and opportunities in Antimicrobial Stewardship & ID Care! Big shoutout to SHEA & the planning committee for their work!

Can’t make it in person? Virtual registration for the HIV and OPAT workshops are open for the MAD-ID & SIDP 2026 Annual Meeting!

@aahiv